Swan-Ganz (S-G)b catheterization provides a sophisticated assessment of cardiac performance not previously attainable in the clinical setting. Measurements of ventricular preload, mixed venous oxygen content, and CO have proven useful for diagnosis and to guide therapy. Although noninvasive monitoring modalities have experienced startling growth over the past decade, S-G catheters remain widely used in the operating room and in critical care settings.
Despite the utility of S-G catheter monitoring, the invasive nature of the technique, as well as recent concerns of the validity of derived measurements, has fostered dissatisfaction with the technique [1] . Owing to the inherent hazards, the technique requires trained personnel, is expensive, and thus can be justified in only a select group of critically ill patients. The validity of measurements derived from S-G catheter data in many settings has been questioned. Two-dimensional echocardiographic (2-D echo) studies have shown pulmonary capillary wedge pressure to be an inaccurate guide to left ventricular preload [2, 3, 4, 5] . As for monitoring myocardial ischemia, van Daele et al. [6] among others have shown that S-G catheter-based indicators, such as acute increases in pulmonary artery wedge pressures, are neither sensitive nor specific. Swan-Ganz measures of CO using the thermodilution technique have an established variability of 10 to 20% and can provide only intermittent assessment of cardiac function [7] . The recent appreciation of these shortcomings has pushed development of alternative approaches to cardiac assessment. While diverse techniques, which include transthoracic bioimpedance, arterial pulse contour, and electrocardiographic R-T ratios, have been examined, it is echocardiography which appears best suited to supplant the method of Swan and Ganz.
Echocardiography can provide noninvasive assessment of cardiac anatomy, valve function, ventricular preload, and blood flow. This has led to extensive use of the technique by cardiologists. Advances in instrumentation have enabled the development of esophageal probes, which contain both 2-D echo and Doppler capabilities. two-dimensional echocardiograph. 397 in the operating room, usually in conjunction with S-G catheters. To replace S-G catheter monitoring, however, an echocardiographic technique to monitor CO is necessary. Despite considerable effort towards this goal, it has been difficult to realize. This paper will briefly discuss the need for direct measures of CO in perioperative care and examine the various echocardiographic approaches to noninvasive CO monitoring.
THE CASE FOR CO MONITORING The importance of determination of CO to manage hemodynamic status is well recognized. Cardiac output reflects upon the heart's performance as a pulsatile pump as modified by vascular tone. Tissue oxygen delivery is the product of CO and arterial blood oxygen content. The clinical utility of CO monitoring is well established. Even experienced clinicians have difficulty in assessing CO. Connors et al. [8] showed that in an intensive care setting a physician's clinical judgement is inadequate to differentiate between high and low CO states. Eisenberg et al. [9] confirmed these results and found that, in the majority of patients, planned therapy was altered by the information obtained from S-G catheterization ( Figure 1 ).
Additional studies have examined the role of CO output monitoring to aid diagnosis and guide therapeutic interventions. A study of vascular surgery patients showed that preoperative maximization of cardiac performance through CO monitoring resulted in significant reductions in postoperative cardiac complications [10] . Rao et al. [11] established that sophisticated cardiac assessment, including CO monitoring, was valuable in the management of surgical patients who had suffered a recent myocardial infarction. Their data shows such monitoring to reduce the incidence, morbidity, and mortality rate of perioperative reinfarction. When optimization of CO and oxygen delivery was set as the therapeutic goal, a prospective study demonstrated that outcome improved in critically ill patients [12] . Thus, development of a continuous, noninvasive technique for assessment of CO would be of considerable clinical significance.
PRINCIPLES OF DOPPLER ULTRASOUND
Ultrasound has rapidly advanced to the forefront of diagnostic imaging. It is capable of both real time imaging of cardiac structures and measuring blood flow within the heart C~~~~~C C 7.0 -t 0~0. which continuously transmits an ultrasound signal and the other which acts as a receiver for reflected signals. The pulsed-wave system employs a single crystal, which acts as both the ultrasound transmitter and receiver. The crystal emits short bursts of ultrasound at regular intervals and pauses between bursts to receive the reflected signal ( the delay between transmission and reception of the reflected signal is dictated by the distance of the reflector from the transducer. By regulating the waiting period from signal transmission to reception, the pulsed wave transducer can select the exact distance from which the reflected signals originated. This capacity, called "range gating", allows the operator to sample blood flow from a specific location in a cardiac chamber or major blood vessel and is a major advantage to pulsed-wave Doppler. The disadvantage of this approach is that the pulsed technique limits the maximum velocities that can be measured to one half the pulse repetition frequency. This maximum frequency shift is known as the Nyquist limit. At frequencies above the Nyquist limit the returning signal becomes distorted ("aliasing"), making the velocity indeterminable. As the depth of the sample volume increases so does the pulse repetition frequency and, thus, the maximum velocities which can be measured becomes limited. A comparison of the advantages of pulsed wave versus continuous wave Doppler measurement techniques is presented in Table 1 .
DOPPLER INSTRUMENTATION
Both pulsed wave and continuous wave Doppler can be used in conjunction with 2-D echo so that the Doppler signal can be directed precisely ( Figure 4 ). This allows the operator to place the beam parallel to blood flow, and, with the pulsed wave technique, permits the selection of a sample volume within the aorta or valve orifice.
SOURCES OF ERROR IN DOPPLER CO DETERMINATION
Although the Doppler approach is theoretically sound and has been validated in experimental flow systems, several potential sources of error become apparent when the technique is applied to the clinical setting [14, 15] . Inaccuracies in the measurement of velocity and CSA can result in erroneous flow measurements.
Errors with cross sectional area determination. Determination of cross sectional area is most commonly derived from equations based on measurements of valve or vessel diameter. This requires an assumption of the geometric shape of the flow chamber. For the aortic and pulmonary valve area measurements, the use of a circular nr2 model appears acceptable. However, the geometry of the mitral and tricuspid valves would be best modeled as an ellipsoid and, thus, require orthogonal 2-D echo images for CSA estimation. In 
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Aorticflow estimates of CO. Most work on determination of CO with Doppler ultrasound has focused on aortic velocity measurements. This approach is appealing, in that many of the conditions required for accurate Doppler measurements are present. The aorta is a concentric, low compliance structure. Additionally, blood flow in the left ventricular outflow tract and proximal aorta has been shown to have a blunt flow pattern [17, 18] .
Doppler signals derived from ascending aortic flow can be reliably obtained from a transcutaneous Doppler probe placed at the suprasternal notch ( Figure 6 ). When combined with a 2-D echo measurement of aortic diameter, CO which are better suited to monitoring purposes.
Transesophageal echocardiography employs an ultrasound transducer mounted on the tip of a steerable esophageal probe. The heart lies anterior to the esophagus and, thus, the transesophageal approach avoids interference from ribs and lung tissue which hampers transthoracic imaging. The close proximity of the esophagus to the cardiac structures enables high resolution images to be obtained. An acoustic window for imaging the descending aorta can be reliably obtained by positioning the probe to a depth of approximately 30 cm (Figure 7) . With the transesophageal approach, the esophagus stabilizes the probe position allowing continuous monitoring. Moreover, obtaining optimal Doppler signals requires only rotation of the probe and adjustments in the depth of insertion.
Determination of transesophageal Doppler estimates of CO using descending aortic flow measurements requires a three step process. First, aortic CSA is estimated by nomogram or a 2-D echo measurement. Second, the esophageal probe is positioned so as to maximize descending aortic flow signals. Third, the descending aortic flow signals are calibrated against a measure of ascending aortic flow. Such a calibration is necessary to account for blood flow distributed to the head and upper extremities and for the significant angle of incidence between the Doppler signal and descending aortic flow. The calibration procedure determines the proportionality constant, K-factor, which is the ratio of ascending aortic to descending aortic flow. Once calibrated, the transesophageal Doppler signals continuously monitor CO based on descending aortic flow.
Non-imaging transesophageal Doppler devices became commercially available in the 1980's. Miniaturization of the transducer allowed for an esophageal probe of 12 FR in diameter including a port for stethoscopy. As anesthesiologists routinely place esophageal stethoscopes for monitoring cardiorespiratory function during general anesthesia, transesophageal CO In an intraoperative evaluation of non-cardiac surgery patients, Perrino et al. [22] reported that real-time display of the Doppler velocity wave form and wide-beam esophageal transducers resulted in a marked reduction in the measurement error of the Doppler technique (Figure 8 ). The improved accuracy of the new generation Doppler devices has been confirmed by Schmid [23] .
A source of error specific to the transesophageal approach to determination of CO is the use of the proportionality constant or K-factor. The K-factor is determined during the initial calibration procedure and is usually not adjusted during the operation. Several studies have suggested that the K-factor can fluctuate during surgery as a response to changes in sympathetic tone, arterial blood pressure, and alterations in anesthetic depth [24, 25, 26, 27] .
Recently, a transesophageal approach has been described for measurement of ascending aortic flow. This technique uses transesophageal echocardiography to obtain an apical long axis view of the left ventricle and proximal aorta. This view is achieved by Figure 9 . Transesophageal echo probe positioned to interrogate ascending aortic flow. anteroflexion of the probe after it is positioned in the stomach (Figure 9 ). After 2-D echo measurement of aortic diameter, a pulsed wave sample volume is placed across the aortic valve using 2-D echo guidance. Katz and colleagues [28] reliably obtained aortic flow signals with this approach and derived CO measurements which correlated with thermodilution measurement. In light of the simplification this technique promises, further evaluation of the approach is warranted.
Transtracheal Doppler is a novel approach for monitoring ascending aortic flow. This technique employs a non-imaging pulsed-wave Doppler crystal mounted to the tip of an endotracheal tube. Positioning at the mid-trachea provides an acoustic window to the ascending aorta (Figure 10 ). The transtracheal approach has several potential advantages for CO monitoring. By incorporating the Doppler crystal into the endotracheal tube, no additional procedures are required. As opposed to the transesophageal approach, no calibration is needed as ascending aortic flow is directly monitored. Also, the pulsed wave signal is used not only to determine blood flow velocity measurements but also to determine the diameter of the flow channel. Thus, an independent echocardiographic measurement of aortic dimensions is unnecessary when using this technique.
Initial work by Abrams et al. [29] showed that transtracheal Doppler CO measurements were highly correlated with thermodilution measurements. Perrino et al. [30] , in a prospective evaluation of the technique in 27 patients undergoing noncardiac surgery, also demonstrated a good correlation with thermodilution measurement (r = 0.80) and found that transtrachional Doppler measurements tracked sequential changes in CO with precision. Transtrachional Doppler performance was found to be dependent on operator experience and the stability of the received Doppler signal. A limitation to the transtracheal approach is that patient positioning and the surgical manipulations associated with open heart surgery significantly increase the error of the technique [31] . Further development of this innovative approach may yield a satisfactory device for clinical use.
Transmitral and transpulmonicflow estimates of CO. Transmitral flow measurement has also been examined as a method for CO determination. Cineangiographic studies by Lynch and Bove [32] showed a flat flow profile at the opening of the mitral valve. Cross sectional area measurement is complicated by the ellipsoid shape of left ventricular inflow tract and the significant variations in mitral valve area during diastole. Fisher et al. [33] described a quantitative technique for CO determination using transmitral flow measurements in an animal model. The flow velocity was sampled at the tips of the mitral valve leaflets and the maximal opening area of the mitral valve seen on a 2-D echo short axis image was corrected for diastolic variations in dimensions M-mode tracings of the leaflets. They accurately estimated CO by this method. Stewart et al. [34] confirmed the need for dynamic assessment of mitral valve area in an experimental preparation. Clinical validation of this approach has followed but difficulties in obtaining a clean, short axis image of the thin pliable mitral leaflets limit its usefulness [35] .
The shortcomings of the Fisher method have led to the search for a simplified technique. Meijboom et al. [36] reported a technique based on 2-D echo and Doppler measurements from a single four-chamber view. Their data in both dogs and children showed this method to be on par with the more complex method of Fisher. Holt [37] described a technique using the apical four chamber view where M-mode tracings of the mitral valve tips were used to estimate the mean mitral valve orifice area. They showed that these estimates closely correlated to 2-D echo measures of mitral valve area and that Doppler CO using this approach accurately estimates thermodilution CO. The above studies confirm the validity of the transmittal approach and, by relying on a single imaging plane, greatly simplify the technique. [40] , in an intraoperative study of transesophageal Doppler, measured mitral CSA at the annulus and velocities from the leaflet tips. Poor correlations with thermodilution were obtained. Further, the error could not be attributed solely to errors in CSA estimation. Shimamoto et al. [41] using both area and velocity measurements obtained at the level of the annulus, also found poor agreement between Doppler and thermodilution CO measurements. Clearly, the utility of mitral flow measurements of CO, as determined by transesophageal Doppler estimations, is not resolved. Accurate measurements appear to require a dynamic assessment of the mitral orifice throughout diastole. The recent development of multiplane echocardiography may also offer improvements in the accuracy of both flow and area measurements.
Doppler measurements of PA blood flow are complicated by systolic variations in vessel CSA and technical imaging difficulties. The transesophageal probe must be anteflexed at the basal short axis view to obtain pulmonary artery measurements. Muhiudeen et al. [40] reported that they were unable to obtain either adequate 2-D echocardiography or Doppler signals of the pulmonary artery in 20 of 140 measurements (14%). They found only a modest correlation between Doppler and thermodilution-determined CO estimates (r = 0.65). Further, sequential changes in Doppler-defined CO were in the opposite direction to changes in thermodilution measurements in 20 of 65 events (31%). More recently, Savino et al. [42] used transesophageal echocardiography to determine CO in 33 cardiac surgery patients. They found pulmonary artery Doppler-defmed estimates to be highly correlated with thermodilution measurements, although they were unable to obtain adequate signals in 24% of patients. This study supports the view that, with careful technique and proper selection of area and velocity measurements, accurate estimates of CO are feasible using data obtained from the pulmonary artery. Its utility for clinical monitoring, however, remains in doubt.
CONCENTRIC BEAM DOPPLER The clinical application of Doppler instrumentation for CO monitoring has been hindered by errors introduced by the unknown angle of incidence between the ultrasound beam and blood flow. This error is important as it effects both CSA and velocity measurements. Use of concentric beam Doppler measurements represents a novel approach to reducing such errors.
The concentric beam Doppler measurement technique consists of a non-imaging pulsed-wave Doppler system which is capable of transmitting and receiving two parallel channel ultrasound beams ( Figure 11 Initial reports by Taylor and Silke [43] in cardiac catheterization patients and by Looyenga et al. [44] in patients in intensive care units showed the concentric beam Doppler device measurements to correlate well with thermodilution measurements. In contrast, subsequent reports have not been favorable, with standard error of the estimates of approximately 1.5 L/min-I [45, 46, 47] . These errors are clearly unacceptable for a clinical monitor and are larger than those obtained with conventional Doppler measurement devices. The varied results from use of the concentric beam Doppler tecnhique can be attributed to both theoretical and practical considerations. In the clinical setting, the operator cannot be assured that the wide beam encompasses the entire aortic flow channel. The diameter of the beam used in the above studies was 30 mm which approximates the diameter of a normal aorta. However, eccentric placement of the ultrasound beam would lead to incomplete interrogation of aortic flow and, thus, underestimation of CSA. Secondly, the operator cannot be assured that the narrow beam will remain focused at the depth appropriate for aortic flow velocity measurements. This could result in additional inaccuracies in the CSA measurement Further, most authors have noted technical difficulties in properly positioning the concentric beam device using the suprasternal approach [43, 45] . Taylor and Silke [43] note that proper aiming of the transducer is critical for reliable performance and these authors recommend that performance of 100 examinations is needed for an operator to become proficient with its use. Niclou 
